chr15-43776886-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025165.3(ELL3):āc.16G>Cā(p.Glu6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,611,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025165.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELL3 | NM_025165.3 | c.16G>C | p.Glu6Gln | missense_variant | 1/11 | ENST00000319359.8 | NP_079441.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELL3 | ENST00000319359.8 | c.16G>C | p.Glu6Gln | missense_variant | 1/11 | 1 | NM_025165.3 | ENSP00000320346.3 | ||
ENSG00000262560 | ENST00000417761.2 | n.*440-342G>C | intron_variant | 2 | ENSP00000415219.2 |
Frequencies
GnomAD3 genomes AF: 0.0000919 AC: 14AN: 152276Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000737 AC: 18AN: 244080Hom.: 0 AF XY: 0.0000678 AC XY: 9AN XY: 132826
GnomAD4 exome AF: 0.000104 AC: 152AN: 1458930Hom.: 0 Cov.: 33 AF XY: 0.000101 AC XY: 73AN XY: 725790
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.16G>C (p.E6Q) alteration is located in exon 1 (coding exon 1) of the ELL3 gene. This alteration results from a G to C substitution at nucleotide position 16, causing the glutamic acid (E) at amino acid position 6 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at